Foloup CV 50/31.25mg Dry Syrup 30ml
Key Information
Generic Name
Generic Name Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg
Manufacturer
Ipca Laboratories Ltd
Country of Origin
India
Detailed Information
Introduction
INTRODUCTION ABOUT FOLOUP CV 50/31.25MG DRY SYRUPFOLOUP CV 50/31.25MG DRY SYRUP is a combination of Cefpodoxime and Clavulanic acid which belongs to the group of medicines called Cephalosporins and Beta-lactamase inhibitors, respectively. FOLOUP CV 50/31.25MG DRY SYRUP is used in children to manage mild to moderate infections such as otitis media (middle ear infection), nose & throat infections, respiratory tract infection, urinary tract infection, reproductive tract infection, and skin infection. FOLOUP CV 50/31.25MG DRY SYRUP is not recommended for use in children allergic to Cefpodoxime, Clavulanic acid, and/or other cephalosporin group of antibiotics. It is also not recommended for use in children suffering from galactose intolerance, Lapp lactase deficiency (lactose intolerance), and glucose-galactose malabsorption (condition marked by body’s inability to absorb glucose and galactose sugars). Before administering FOLOUP CV 50/31.25MG DRY SYRUP, inform your doctor if the child has previous history of hypersensitivity reactions to medicines such as cefpodoxime, other cephalosporins, penicillin, and/or have kidney problems (such as mild/moderate/severe renal impairment), and liver problems (such as hepatic insufficiency/impairment). FOLOUP CV 50/31.25MG DRY SYRUP is not recommended for use in pregnant and breastfeeding women since it is used only in children (aged below 12 years). It is also not recommended for use in elderly patients. The most common
Uses
OF FOLOUP CV 50/31.25MG DRY SYRUPUsed in paediatric patients: To manage mild to moderate infections such as otitis media (middle ear infection), nose & throat infections, respiratory tract infection, urinary tract infection, reproductive tract infection, and skin infection
How It Works
FOLOUP CV 50/31.25MG DRY SYRUP helps to manage mild to moderate infections, where Cefpodoxime works by managing the formation of the protective covering of the bacteria which is essential for the survival of bacteria and Clavulanic acid works by reducing the resistance and enhancing the activity of Cefpodoxime against bacteria thus managing the occurrence of infections in affected children.
Directions for Use
Dry Syrup/ Oral Suspension: Administer FOLOUP CV 50/31.25MG DRY SYRUP as advised by your physician. Shake the dry powder loose and reconstitute the dry powder in required quantity of water before consuming. Your doctor will decide the exact dose and duration of management for your child depending on child’s age, body weight and disease condition. Syrup: Administer FOLOUP CV 50/31.25MG DRY SYRUP as advised by your physician. Shake well before use. Your doctor will decide the exact dose and duration of management for your child depending on child’s age, body weight and disease condition.
Side Effects
administering FOLOUP CV 50/31.25MG DRY SYRUP in child are diarrhoea, nausea, vomiting, abdominal pain, headache, vaginal fungal infections, and/or vulvovaginal infections. Consult your doctor if any of these symptoms worsens. USES OF FOLOUP CV 50/31.25MG DRY SYRUPUsed in paediatric patients: To manage mild to moderate infections such as otitis media (middle ear infection), nose & throat infections, respiratory tract infection, urinary tract infection, reproductive tract infection, and skin infection HOW FOLOUP CV 50/31.25MG DRY SYRUP WORKSFOLOUP CV 50/31.25MG DRY SYRUP helps to manage mild to moderate infections, where Cefpodoxime works by managing the formation of the protective covering of the bacteria which is essential for the survival of bacteria and Clavulanic acid works by reducing the resistance and enhancing the activity of Cefpodoxime against bacteria thus managing the occurrence of infections in affected children. DIRECTIONS FOR USEDry Syrup/ Oral Suspension: Administer FOLOUP CV 50/31.25MG DRY SYRUP as advised by your physician. Shake the dry powder loose and reconstitute the dry powder in required quantity of water before consuming. Your doctor will decide the exact dose and duration of management for your child depending on child’s age, body weight and disease condition. Syrup: Administer FOLOUP CV 50/31.25MG DRY SYRUP as advised by your physician. Shake well before use. Your doctor will decide the exact dose and duration of management for your child depending on child’s age, body weight and disease condition. SIDE EFFECTS OF FOLOUP CV 50/31.25MG DRY SYRUPCOMMON Diarrhoea, vomiting Diaper rash/fungal skin rash Non-fungal skin rash UNCOMMON Localized/generalized abdominal pain, abdominal cramp, headache, weakness, fever, fungal infection Nausea, altered taste, anorexia (eating disorder), dry mouth, oral mucositis, pseudomembranous colitis (inflammation of colon) Thrombocythemia (low platelet count) Muscle spasm/pain, hallucination, nervousness, excessive sleepiness Bleeding from nose, stuffy nose Fungal infection of skin and nail, red itchy welts, acne, exfoliative dermatitis (severe inflammation of skin), rash RAREStop administering FOLOUP CV 50/31.25MG DRY SYRUP and consult your doctor immediately in case the child experiences: Signs of allergic reactions such as runny nose, sneezing, breathlessness, itchy skin, and/or raised rash Seizures
Warnings & Precautions
& PRECAUTIONSPREGNANCYContraindicatedFOLOUP CV 50/31.25MG DRY SYRUP is not recommended for use in pregnant women as it is used only in children. BREASTFEEDINGContraindicatedFOLOUP CV 50/31.25MG DRY SYRUP is not recommended for use in breastfeeding women as it is used only in children. KIDNEYUse with CautionFOLOUP CV 50/31.25MG DRY SYRUP should be administered with caution in children with kidney problems such as mild, moderate, and severe renal impairment. Consult your doctor before administering FOLOUP CV 50/31.25MG DRY SYRUP to the child. LIVERUse with CautionFOLOUP CV 50/31.25MG DRY SYRUP should be administered with caution in children with liver problems such as hepatic impairment/insufficiency. Consult your doctor before administering FOLOUP CV 50/31.25MG DRY SYRUP to the child. ALLERGYContraindicatedFOLOUP CV 50/31.25MG DRY SYRUP should be administered with caution in children with liver problems such as hepatic impairment/insufficiency. Consult your doctor before administering FOLOUP CV 50/31.25MG DRY SYRUP to the child. USE IN PEDIATRICSConsult your doctorFOLOUP CV 50/31.25MG DRY SYRUP is recommended for use in children (aged below 12 years). Consult your doctor before administering the medicine to infants (less than 2 years) as safety and efficacy of the medicine have not been established. USE IN GERIATRICSContraindicatedFOLOUP CV 50/31.25MG DRY SYRUP is not recommended for use in elderly patients as it is used only in children. OTHERSFOLOUP CV 50/31.25MG DRY SYRUP is not recommended for use in child, if it has: Galactose intolerance, Lapp lactase deficiency (lactose intolerance), glucose-galactose malabsorption (condition marked by inability of the body to absorb glucose and galactose sugars) Before taking FOLOUP CV 50/31.25MG DRY SYRUP inform your doctor if the child has: Previous hypersensitivity reactions to cefpodoxime, other cephalosporins, penicillin, and/or other medicines
Drug Interactions
SA. Drug-Drug Interactions: Before administering FOLOUP CV 50/31.25MG DRY SYRUP, inform your doctor, if your child is taking any of the following medicine: Antacids (medicines used to relieve indigestion and heartburn) Ex. sodium bicarbonate, aluminium hydroxide Probenecid (used to manage gout) Nephrotoxic drugs (medicines that can damage kidney via various mechanisms) Ex. aminoglycosides, amphotericin B Overdosage: If the child or anyone else accidentally take too much of FOLOUP CV 50/31.25MG DRY SYRUP, consult and inform your doctor immediately or visit the nearby hospital. The symptoms of overdosage of FOLOUP CV 50/31.25MG DRY SYRUP may include nausea, vomiting, epigastric distress, and diarrhoea. SYNOPSIS Drug : Cefpodoxime, Clavulanic Acid Pharmacological Category : Cephalosporins, Beta-lactamase inhibitors Therapeutic Indication : Mild to moderate infections (caused by susceptible strains of microorganisms) in children Dosage Forms : Tablet, Dispersible Tablet, Dry Syrup, Dry Suspension, Oral Suspension, Suspension, Syrup MORE INFORMATIONSTORAGE Keep FOLOUP CV 50/31.25MG DRY SYRUP out of reach of children Store FOLOUP CV 50/31.25MG DRY SYRUP below 25°C
Frequently Asked Questions
Common questions and answers about Foloup CV 50/31.25mg Dry Syrup 30ml.
What is FOLOUP CV 50/31.25MG DRY SYRUP used for?
FOLOUP CV 50/31.25MG DRY SYRUP is used in children to manage mild to moderate infections such as otitis media (middle ear infection), nose & throat infections, respiratory tract infection, urinary tract infection, reproductive tract infection, and skin infection.
How FOLOUP CV 50/31.25MG DRY SYRUP works?
FOLOUP CV 50/31.25MG DRY SYRUP helps to manage mild to moderate infections, where Cefpodoxime works by managing the formation of the protective covering of the bacteria which is essential for the survival of bacteria and Clavulanic acid works by reducing the resistance and enhancing the activity of Cefpodoxime against bacteria thus managing the occurrence of infections in affected children.
What are the most common side effects of taking FOLOUP CV 50/31.25MG DRY SYRUP?
The most common side effects of administering FOLOUP CV 50/31.25MG DRY SYRUP in child are diarrhoea, nausea, vomiting, abdominal pain, headache, vaginal fungal infections, and/or vulvovaginal infections. Consult your doctor if any of these symptoms worsens.
Can FOLOUP CV 50/31.25MG DRY SYRUP cause diarrhoea?
Yes, FOLOUP CV 50/31.25MG DRY SYRUP causes diarrhoea as it is the most common side effect associated with the use of medicine. If such side effects experienced, then ask the child to drink lots of fluids such as water or fruit juices so that the child is sufficiently hydrated. Do not administer any medicine to manage the condition on your own. Consult your doctor if the symptom does not improve or becomes worse.
How FOLOUP CV 50/31.25MG DRY SYRUP is administered in the child?
Administer FOLOUP CV 50/31.25MG DRY SYRUP in child as advised by your physician. Shake the dry powder loose and reconstitute the dry powder in required ml of water before consuming. Your doctor will decide the exact dose and duration of management for your child depending on child’s age, body weight and disease condition.
Article Information
Written By
DETAILS Written By Dr. N. Sai Swaroop
Medical Content Writer
Reviewed By
Dr. Sankara Babu Gorle
Medical Expert
Last Updated
26 Jul 2024